Novo Holdings A/S as of Dec. 31, 2020
Portfolio Holdings for Novo Holdings A/S
Novo Holdings A/S holds 45 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Index Fds Total Stk Mkt (VTI) | 16.1 | $376M | 1.9M | 194.64 | |
| Nkarta (NKTX) | 7.4 | $172M | 2.8M | 61.47 | |
| Inogen (INGN) | 6.8 | $159M | 3.5M | 44.68 | |
| Apple (AAPL) | 5.9 | $138M | 1.0M | 132.69 | |
| Praxis Precision Medicines I | 5.8 | $134M | 2.4M | 55.02 | |
| Harmony Biosciences Hldgs In (HRMY) | 5.6 | $131M | 3.6M | 36.15 | |
| Brookfield Asset Mgmt Cl A Ltd Vt Sh | 5.4 | $127M | 3.1M | 41.27 | |
| Spruce Biosciences (SPRB) | 5.2 | $121M | 5.0M | 24.31 | |
| Cable One (CABO) | 5.0 | $117M | 52k | 2227.72 | |
| Catalent (CTLT) | 4.4 | $104M | 997k | 104.07 | |
| Morphic Hldg (MORF) | 3.8 | $89M | 2.6M | 33.55 | |
| Aligos Therapeutics (ALGS) | 3.1 | $72M | 2.6M | 27.65 | |
| Inozyme Pharma (INZY) | 2.3 | $53M | 2.6M | 20.64 | |
| Freeline Therapeutics Hldgs Sponsored Ads | 1.8 | $43M | 2.4M | 18.26 | |
| Mirum Pharmaceuticals (MIRM) | 1.8 | $43M | 2.4M | 17.46 | |
| Amicus Therapeutics (FOLD) | 1.7 | $39M | 1.7M | 23.09 | |
| Eargo | 1.4 | $33M | 737k | 44.82 | |
| Checkmate Pharmaceuticals In | 1.4 | $32M | 2.2M | 14.59 | |
| Galecto (GLTO) | 1.3 | $31M | 2.5M | 12.51 | |
| Galera Therapeutics (GRTX) | 1.3 | $30M | 3.0M | 10.23 | |
| Seaspine Holdings | 1.0 | $23M | 1.3M | 17.45 | |
| Blueprint Medicines (BPMC) | 0.9 | $22M | 197k | 112.15 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.8 | $18M | 2.6M | 7.00 | |
| Iovance Biotherapeutics (IOVA) | 0.8 | $18M | 384k | 46.40 | |
| Protagonist Therapeutics (PTGX) | 0.7 | $18M | 868k | 20.16 | |
| Constellation Pharmceticls I | 0.7 | $17M | 599k | 28.80 | |
| Milestone Pharmaceuticals (MIST) | 0.7 | $17M | 2.5M | 6.70 | |
| Flexion Therapeutics | 0.7 | $16M | 1.4M | 11.54 | |
| Insmed Com Par $.01 (INSM) | 0.6 | $14M | 430k | 33.29 | |
| Pulmonx Corp (LUNG) | 0.6 | $13M | 187k | 69.02 | |
| Kinnate Biopharma (KNTE) | 0.5 | $12M | 300k | 39.78 | |
| Intersect Ent | 0.5 | $12M | 502k | 22.90 | |
| Spero Therapeutics (SPRO) | 0.5 | $11M | 577k | 19.39 | |
| Vaxcyte (PCVX) | 0.5 | $11M | 417k | 26.57 | |
| Aerie Pharmaceuticals | 0.5 | $11M | 808k | 13.51 | |
| Akouos | 0.4 | $9.1M | 459k | 19.83 | |
| Inspire Med Sys (INSP) | 0.3 | $7.5M | 40k | 188.10 | |
| Acutus Medical (AFIB) | 0.3 | $7.3M | 255k | 28.81 | |
| Biohaven Pharmaceutical Holding | 0.3 | $7.1M | 83k | 85.72 | |
| Zogenix Com New | 0.3 | $6.5M | 326k | 19.99 | |
| Inari Medical Ord (NARI) | 0.3 | $6.3M | 72k | 87.28 | |
| Silk Road Medical Inc Common (SILK) | 0.2 | $5.0M | 80k | 62.98 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.2 | $3.8M | 271k | 14.11 | |
| Corvus Pharmaceuticals (CRVS) | 0.1 | $3.0M | 848k | 3.56 | |
| F-star Therapeutics | 0.0 | $344k | 35k | 9.88 |
